查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
介入性超音波市場-全球及區域分析：按應用、最終用戶及區域-分析與預測（2025-2035）
市場調查報告書
商品編碼
1798386

介入性超音波市場-全球及區域分析：按應用、最終用戶及區域-分析與預測（2025-2035）

Interventional Ultrasound Market - A Global and Regional Analysis: Focus on Application, End User, and Region - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 134 Pages | 商品交期: 1-5個工作天內

價格

到2024年全球介入超音波市場規模達到 22.387億美元。

預計到2035年，市場規模將快速成長至 42.237億美元，2025年至2035年期間的年複合成長率將達到 6.05%。

主要市場統計資料
預測期 2025-2035
2025年評估 23.48億美元
2035年的預測 42.237億美元
年複合成長率 6.05%

這種穩定成長的驅動力源於人們對微創治療日益成長的偏好、全球慢性病負擔的不斷加重，以及影像引導介入技術在心臟病學和腫瘤學等臨床專科中的廣泛應用。介入性超音波相較於傳統治療方式具有許多優勢，包括即時導引、低輻射暴露和成本效益，使其在住院和門診環境中都越來越具有吸引力。

造影超音波、彈性成像和基於人工智慧的自動化等技術創新進一步提高介入性超音波系統的準確性、易用性和診斷價值。然而，諸如對操作員的依賴性、影像品質參差不齊以及某些地區的償付挑戰等限制因素可能會阻礙市場滲透。儘管存在這些障礙，但持續的研發投入、日益成長的臨床應用以及對即時非輻射成像日益成長的需求預計將支持介入超音波市場的持續擴張。

市場介紹

介入性超音波市場正經歷重大變革時期期，推動力來自持續的技術進步、策略性合作夥伴關係以及強調微創、即時、影像引導介入的不斷擴大的臨床應用。各公司將人工智慧、3D 成像、彈性成像和造影超音波整合到他們的平台中，以提高程式準確性和工作流程效率。GE HealthCare的Versana Premier、Canon Inc.的Aplio i 系列和Siemens Healthineers AG支援人工智慧的介入性超音波系統等創新反映了這一趨勢。策略性收購和研發投資進一步擴大產品系列加強市場佔有率。隨著超音波導引切片檢查、腫瘤消融和血管通路手術越來越廣泛的應用，介入超音波日益成為現代影像導引治療方法的基石，為各種臨床環境中提供精確、安全和無輻射的選擇。

對產業的影響

全球介入超音波市場正經歷臨床實踐的重大轉變，這得益於各種治療程序對即時無輻射成像解決方案日益成長的需求。Canon、Esaote SPA、GE HealthCare、Koninklijke Philips N.V.、Siemens Healthineers AG等行業領導者在推動介入性超音波技術發展方面發揮核心作用，該技術超越了傳統的診斷應用，並支持精準引導介入。這些系統是腫瘤科、心臟科和急診醫學領域的重要工具，能夠在最大程度減少患者創傷的同時實現針對性治療。透過簡化複雜的程序、減少對透視和CT的依賴，並提高門診病人和資源匱乏地區醫療服務的可近性，介入性超音波有助於提高醫療服務的效率並改善手術效果。不斷擴展的臨床能力以及對全球微創和價值導向醫療趨勢的支持，將進一步影響該市場。

市場區隔

細分1：依應用

  • 一般外科
  • 癌症
  • 心內和血管
  • 其他

一般外科領域在介入性超音波市場佔據主導地位（依應用）

從應用角度來看，全球介入性超音波市場將以一般外科手術為主導，到2024年將佔據39.8%的市場。該領域佔據主導地位的主要原因在於其廣泛的臨床效用以及微創手術系統的日益普及。介入性超音波在一般外科手術的應用日益廣泛，用於即時引導切片檢查、體液引流、腫瘤切除、血管通路等。它能夠提供動態即時影像，無需放射線照射，使其成為術中決策和精準定位的理想選擇。

細分 2：依最終用戶

  • 醫院和診所
  • 門診手術中心
  • 其他（用於研究目的）

醫院和診所部門主導介入性超音波市場（依最終用戶）

從終端用戶來看，醫院和診所將主導全球介入超音波市場，到2024年將佔據 79.1%的市場。醫院和診所憑藉其在提供先進、大容量和多學科介入治療方面的關鍵作用，在終端用戶介入超音波市場中佔據主導地位。擁有最先進基礎設施、熟練醫療專業人員和普通外科、腫瘤科、循環系統和急診部科等專科部門的醫院，最適合部署和利用介入超音波系統進行各種手術。這些系統能夠在微創干預期間提供精確、即時的指導，這對於最終改善手術結果和縮短患者康復時間非常重要。醫院和診所投資下一代技術（如人工智慧整合和可攜式超音波平台）的能力，進一步鞏固了主導。此外，臨床環境向門診病人和日間護理環境的轉變也加強了市場佔有率，使醫院和診所成為全球介入性超音波應用的關鍵。

細分 3：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

預計亞太地區介入超音波市場在預測期內將以7.06%的顯著速度成長。這一強勁的成長軌跡受到多種因素的推動，包括醫療基礎設施的快速發展、對微創手術的需求不斷成長，以及即時成像技術在照護端的日益普及。亞太地區擁有一些技術最先進的醫院和學術機構，尤其是在中國、日本、韓國和印度等國家，這些國家增加對精準醫療和影像引導治療的投資。此外，該地區龐大的患者群體以及癌症、心血管疾病和肝病等慢性疾病盛行率的上升，推動各專業對介入性超音波的需求。

介入超音波市場的最新趨勢

  • 2024年 2月，Canon Inc.宣布推出 Aplio Beyond，這是一款緊湊、環保的超音波診斷系統，整合了先進的成像功能和人體工學設計，可改善臨床工作流程和患者照護。
  • 2025年 1月，GE HealthCare 的Voluson Expert 系列超音波診斷設備（包括 Voluson Expert 22、20 和 18）獲得了 FDA 510（k）許可。 Voluson Expert 22、20 和 18 整合了先進的人工智慧功能、增強的影像處理工具和人體工學設計，可提高女性醫療保健（尤其是高風險懷孕）的工作流程效率和診斷準確性。
  • 2024年 8月，Koninklijke Philips N.V.與 Carrion Clinic 合作，在 Crystal Spring Tower 的新心血管研究所安裝了 11 間先進的介入套件。
  • 2024年4月，Esaote Group將透過其子公司Esaote Asia-Pacific Diagnostic Private Limited在印度北方邦建立新的製造工廠，為當地市場生產先進的印度製造超音波診斷系統。該廠將提供MyLab A、MyLab E系列以及配備人工智慧增強洞察技術和創新觸控螢幕控制的緊湊型可攜式型號。

需求 - 促進因素、挑戰、機會

市場促進因素

微創手術需求不斷成長：微創手術需求不斷成長是介入超音波市場的主要驅動力。微創手術透過提供優於傳統開放性手術的獨特優勢（包括降低感染風險和顯著縮短恢復時間）而改變醫療保健格局。據 Paragon Surgical Center表示，接受微創手術的患者可以在幾天到幾週內恢復正常活動，而開放性手術通常需要較長的恢復期。介入性超音波透過提供即時、無輻射成像，能夠在切片檢查、腫瘤切除和血管通路等手術過程中實現精確定位，在這一轉變中發揮核心作用。這不僅可以最大限度地減少附帶組織損傷，還可以提高手術的準確性和安全性。此外，隨著全球慢性病負擔的增加以及患者偏好轉向更快、侵入性更小的治療，介入性超音波系統預計將在各種臨床環境中加速普及。

市場挑戰

高成本：儘管先進介入超音波系統具有臨床益處，但其高昂的成本仍然是其廣泛應用的重大障礙，尤其是在成本敏感且資源有限的環境中。配備人工智慧驅動軟體和造影功能的高階超音波平台需要大量的資本投入，這使得小型診所和公立醫療機構難以獲得這些平台。此外，與程序相關的成本，例如一次性設備和持續維護，可能會進一步加劇醫療保健預算的壓力。這些成本限制限制了在農村和服務欠缺地區的部署，因為這些地區獲得先進診斷成像的機會已經有限。解決這些可負擔性挑戰對於在全球範圍內更公平地應用介入性超音波技術非常重要。

市場機會

新興市場擴張：新興市場為介入性超音波市場提供了巨大的成長機會，這得益於醫療保健投資的增加、基礎設施的改善以及人們對微創技術的日益重視。亞太地區、拉丁美洲和中東地區的醫療保健成本快速成長，慢性病負擔也日益加重，這推動了對可擴展、經濟高效的影像解決方案的需求。此外，各國政府和全球醫療保健組織為改善診斷和治療工具的可近性所做的努力，加速介入超音波系統的普及。透過本地夥伴關係、培訓計畫和區域特定產品線來擴大影響力的市場參與企業，可以從這些快速成長的經濟體尚未開發的潛力中獲益匪淺。

產品/創新策略：全球介入超音波市場已根據應用、最終用戶、地區等不同類別進行了廣泛細分。這有助於讀者清楚了解哪個細分市場佔有最大佔有率以及哪個細分市場在未來幾年可能會成長。

成長/行銷策略：在主要發展中，新開發最為普遍，佔2021年 1月至2025年 5月全球介入性超音波市場總發展量的約 58.1%。

競爭策略：全球介入超音波市場擁有大量現有參與者及其產品系列。本研究分析和描述的全球介入性超音波市場主要企業概況包括提供介入性超音波系統產品的現有參與者。

本報告研究了全球介入超音波市場，並提供了市場概述、應用、最終用戶和地區的趨勢以及參與市場的公司概況。

目錄

執行摘要

第1章 全球介入超音波市場：產業展望

  • 主要市場趨勢
    • 影響分析
    • 將人工智慧整合到超音波系統中
    • 增加超音波系統產品的推出
  • 專利分析
  • 監管狀況
    • 美國
    • 歐洲
    • 亞太地區
  • 定價分析
  • 市場動態
    • 市場促進因素
    • 市場挑戰
    • 市場機會

第2章 全球介入性超音波市場（依應用），2023-2035

  • 一般外科
  • 癌症
  • 心血管醫學
  • 其他

第3章 2023-2035年全球介入性超音波市場（依最終用戶）

  • 醫院和診所
  • 門診手術中心
  • 其他

第4章 2023-2035年全球介入性超音波市場（依地區）

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第5章 競爭格局與公司概況

  • 競爭格局
  • 公司簡介
    • Canon Inc.
    • DeepSight Technology, Inc.
    • Edan Instruments
    • Esaote SPA
    • FUJIFILM Holdings Corporation
    • GE HealthCare
    • Konica Minolta, Inc.
    • Koninklijke Philips NV
    • Samsung Healthcare
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Siemens Healthineers AG
    • SonoScape Medical Corp.

第6章 調查方法

Product Code: BHR2914SA

This report can be delivered within 1 working day.

Introduction of Interventional Ultrasound Market

The global interventional ultrasound market, initially valued at $2,238.7 million in 2024, is projected to witness substantial growth, surging to $4,223.7 million by 2035, marking a remarkable compound annual growth rate (CAGR) of 6.05% over the period from 2025 to 2035.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$2,348.0 Million
2035 Forecast$4,223.7 Million
CAGR6.05%

This steady growth is being driven by the increasing preference for minimally invasive procedures, a rising global burden of chronic diseases, and the expanding use of image-guided interventions across clinical specialties such as cardiology and oncology. Interventional ultrasound offers several advantages over traditional modalities, including real-time guidance, reduced radiation exposure, and cost-effectiveness, making it increasingly attractive for both hospital and outpatient settings.

Technological innovations, such as the incorporation of contrast-enhanced ultrasound, elastography, and artificial intelligence-based automation, are further enhancing the precision, usability, and diagnostic value of interventional ultrasound systems. However, limitations such as operator dependency, variability in image quality, and reimbursement challenges in certain regions may constrain market penetration. Despite these barriers, ongoing R&D efforts, increasing clinical applications, and growing demand for real-time, non-radiative imaging are expected to support the sustained expansion of the interventional ultrasound market.

Market Introduction

The interventional ultrasound market has been undergoing significant transformation, driven by continuous technological advancements, strategic partnerships, and expanding clinical applications that emphasize minimally invasive, real-time image-guided interventions. Companies are increasingly integrating artificial intelligence, 3D imaging, elastography, and contrast-enhanced ultrasound into their platforms to enhance procedural accuracy and workflow efficiency. Innovations such as GE HealthCare's Versana Premier, Canon Inc.'s Aplio i-series, and Siemens Healthineers AG's AI-enabled interventional ultrasound systems reflect this trend. Strategic acquisitions and R&D investments are further broadening product portfolios and reinforcing market presence. As ultrasound-guided biopsies, tumor ablation, and vascular access procedures become more widely adopted, interventional ultrasound is increasingly positioned as a cornerstone of modern image-guided therapeutics, offering precision, safety, and radiation-free alternatives across diverse clinical settings.

Industrial Impact

The global interventional ultrasound market has been experiencing a notable shift in clinical practice, driven by growing demand for real-time, radiation-free imaging solutions across a wide range of therapeutic procedures. Industry leaders such as Canon Inc., Esaote SPA, GE HealthCare, Koninklijke Philips N.V., and Siemens Healthineers AG have been playing a central role in advancing interventional ultrasound technologies that support precision-guided interventions beyond traditional diagnostic applications. These systems are critical tools in oncology, cardiology, and emergency medicine, enabling targeted treatments with minimal patient trauma. By streamlining complex procedures, reducing reliance on fluoroscopy or CT, and enhancing access in outpatient and resource-limited settings, interventional ultrasound has been contributing to more efficient care delivery and improved procedural outcomes. The market's industrial impact is further amplified by its role in broadening clinical capabilities and supporting the global trend toward minimally invasive, value-based healthcare.

Market Segmentation:

Segmentation 1: by Application

  • General Surgery
  • Cancer
  • Cardiac and Endovascular
  • Others

General Surgery Segment to Dominate the Interventional Ultrasound Market (by Application)

Based on application, the global interventional ultrasound market was led by general surgery, which held a 39.8% share in 2024. The segment dominates the market primarily due to its broad clinical utility and increasing adoption of minimally invasive surgical systems. Interventional ultrasound is increasingly being used in general surgical procedures for real-time guidance in biopsies, fluid drainage, tumor ablation, and vascular access. Its ability to provide dynamic, real-time imaging without radiation exposure makes it an ideal modality for intraoperative decision-making and precision targeting.

Segmentation 2: by End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others (Research Use)

Hospitals and Clinics Segment to Dominate the Interventional Ultrasound Market (by End User)

Based on end user, the global interventional ultrasound market was led by the hospitals and clinics segment, which held a 79.1% share in 2024. Hospitals and clinics dominate the interventional ultrasound market based on end-users due to the pivotal role hospitals and large clinical centers play in delivering advanced, high-volume, and multidisciplinary interventional care. Equipped with state-of-the-art infrastructure, skilled healthcare professionals, and dedicated departments such as general surgery, oncology, cardiology, and emergency medicine, hospitals are ideally positioned to adopt and utilize interventional ultrasound systems for a wide range of procedures. These systems are essential for enabling precise, real-time guidance during minimally invasive interventions, ultimately improving procedural outcomes and reducing patient recovery times. The capacity of hospitals and clinics to invest in next-generation technologies, including AI-integrated and portable ultrasound platforms, further supports their leadership in this segment. Moreover, the increasing shift toward outpatient and day-care procedures within clinical settings continues to reinforce their market share, making hospitals and clinics the cornerstone of interventional ultrasound adoption globally.

Segmentation 3: by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • France
    • Germany
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest-of-Latin America
  • Middle East and Africa

The interventional ultrasound market in the Asia-Pacific region is expected to witness a significant growth rate of 7.06% during the forecast period. This strong growth trajectory is driven by a combination of factors, including rapid advancements in healthcare infrastructure, rising demand for minimally invasive procedures, and the increasing adoption of real-time imaging technologies across surgical and diagnostic settings. Asia-Pacific is home to some of the most technologically advanced hospitals and academic institutions, particularly in countries such as China, Japan, South Korea, and India, where there is growing investment in precision medicine and image-guided therapies. Additionally, the region's large patient population and increasing prevalence of chronic conditions such as cancer, cardiovascular disease, and liver disorders have been fueling the demand for interventional ultrasound across a variety of specialties.

Recent Developments in the Interventional Ultrasound Market

  • In February 2024, Canon Inc. introduced the Aplio beyond, a compact, eco-friendly ultrasound system that integrates advanced imaging capabilities with ergonomic design, aiming to enhance clinical workflows and patient care.
  • In January 2025, GE HealthCare has received FDA 510(k) clearance for its updated Voluson Expert Series ultrasound systems, including the Voluson Expert 22, 20, and 18, which integrate advanced artificial intelligence features, enhanced imaging tools, and ergonomic design to improve workflow efficiency and diagnostic accuracy in women's healthcare, particularly for high-risk pregnancies.
  • In August 2024, Koninklijke Philips N.V. partnered with Carilion Clinic to equip the new Cardiovascular Institute at Crystal Spring Tower with 11 advanced interventional suites, integrating cutting-edge imaging and ultrasound technologies to enhance cardiovascular care and optimize clinical performance for complex procedures.
  • In April 2024, Esaote Group established a new manufacturing facility in Uttar Pradesh, India, through its subsidiary Esaote Asia-Pacific Diagnostic Private Limited, to produce advanced Made in India ultrasound systems for the local market. The site is expected to deliver the MyLab A, MyLab E series, and compact portable models, all featuring AI-powered augmented insight technology and innovative touchscreen controls.

Demand - Drivers, Challenges, and Opportunities

Market Drivers

Rising Demand for Minimally Invasive Procedures: The increasing demand for minimally invasive procedures is a key driver of the interventional ultrasound market. Minimally invasive techniques have been transforming the healthcare landscape by offering clear advantages over traditional open surgeries, including a lower risk of infection and significantly faster recovery times. According to Paragon Surgical Center, patients undergoing minimally invasive treatments can typically resume normal activities within days or weeks, compared to the extended recovery periods associated with open surgeries. Interventional ultrasound plays a central role in this transformation by providing real-time, radiation-free imaging that allows for precise targeting during procedures such as biopsies, tumor ablations, and vascular access. This not only minimizes collateral tissue damage but also enhances procedural accuracy and safety. Further, as the global burden of chronic conditions rises and patient preferences shift toward quicker and less invasive treatments, the adoption of interventional ultrasound systems is expected to accelerate across diverse clinical settings.

Market Challenges

High Cost of Equipment and Procedures: Despite its clinical benefits, the high cost associated with advanced interventional ultrasound systems remains a significant barrier to broader adoption, particularly in cost-sensitive and resource-limited environments. High-end ultrasound platforms equipped with AI-driven software and contrast-enhanced imaging features demand substantial capital investment, making them less accessible to smaller clinics or public healthcare institutions. Moreover, procedure-related expenses, including disposable instruments and ongoing maintenance, can further strain healthcare budgets. These cost constraints limit deployment in rural and underserved regions, where access to advanced imaging is already restricted. Addressing these affordability challenges is expected to be crucial to achieving more equitable adoption of interventional ultrasound technology worldwide.

Market Opportunities

Expansion in Emerging Markets: Emerging markets present a substantial growth opportunity for the interventional ultrasound market, driven by rising healthcare investments, improving infrastructure, and increasing awareness of minimally invasive techniques. Countries in Asia-Pacific, Latin America, and the Middle East have been witnessing rapid growth in healthcare expenditure and a growing burden of chronic diseases, creating demand for scalable and cost-effective imaging solutions. Additionally, initiatives by governments and global health organizations to improve access to diagnostic and therapeutic tools are accelerating the adoption of interventional ultrasound systems. Market players expanding their presence through local partnerships, training programs, and region-specific product lines stand to benefit significantly from the untapped potential in these fast-growing economies.

How can this report add value to an organization?

Product/Innovation Strategy: The global interventional ultrasound market has been extensively segmented based on various categories, such as application, end user, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: New offerings accounted for the maximum number of key developments, i.e., nearly 58.1% of the total developments in the global interventional ultrasound market were between January 2021 and May 2025.

Competitive Strategy: The global interventional ultrasound market has numerous established players with product portfolios. Key players in the global interventional ultrasound market analyzed and profiled in the study include established players offering products for interventional ultrasound systems.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2024. A historical year analysis has been done for the period FY2022-FY2023. The market size has been estimated for FY2024 and projected for the period FY2025-FY2035.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report presents a comprehensive market study of the upstream and downstream products in the interventional ultrasound market.
  • The market contribution of interventional ultrasound is anticipated to be launched in the future and has been calculated based on the historical analysis of the solutions.
  • Revenues of the companies have been referenced from their annual reports for FY2023 and FY2024. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
  • The market has been mapped based on the available interventional ultrasound systems. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research

The primary sources involve industry experts in interventional ultrasound, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Validation of the numbers of the different segments of the market in focus
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and a detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • Segmentations and percentage shares
  • Data for market value
  • Key industry trends of the top players in the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Canon Inc.
  • DeepSight Technology, Inc.
  • Edan Instruments
  • Esaote SPA
  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Konica Minolta, Inc.
  • Koninklijke Philips N.V.
  • Samsung Healthcare
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • SonoScape Medical Corp.

Table of Contents

Executive Summary

Scope and Definition

1 Global Interventional Ultrasound Market: Industry Outlook

  • 1.1 Key Market Trends
    • 1.1.1 Impact Analysis
    • 1.1.2 Integration of Artificial Intelligence in Ultrasound Systems
    • 1.1.3 Increase in Ultrasound System Product Launch
  • 1.2 Patent Analysis
    • 1.2.1 Patent Filing Trend (by Country)
    • 1.2.2 Patent Filing Trend (by Year)
  • 1.3 Regulatory Landscape
    • 1.3.1 U.S.
    • 1.3.2 Europe
    • 1.3.3 Asia-Pacific
      • 1.3.3.1 China
      • 1.3.3.2 Japan
      • 1.3.3.3 India
      • 1.3.3.4 Australia
  • 1.4 Pricing Analysis
  • 1.5 Market Dynamics
    • 1.5.1 Market Drivers
      • 1.5.1.1 Rising Demand for Minimally Invasive Procedures
      • 1.5.1.2 Growing Prevalence of Chronic Diseases
      • 1.5.1.3 Technological Advancements
    • 1.5.2 Market Challenges
      • 1.5.2.1 High Cost of Equipment and Procedures
      • 1.5.2.2 Shortage of Skilled Professionals
    • 1.5.3 Market Opportunities
      • 1.5.3.1 Expansion in Emerging Markets

2 Global Interventional Ultrasound Market (by Application), ($Million), 2023-2035

  • 2.1 General Surgery
  • 2.2 Cancer
    • 2.2.1 Lung Cancer
    • 2.2.2 Breast Cancer
    • 2.2.3 Liver Cancer
    • 2.2.4 Kidney Cancer
    • 2.2.5 Prostate Cancer
    • 2.2.6 Others
  • 2.3 Cardiac and Endovascular
  • 2.4 Others

3 Global Interventional Ultrasound Market (by End User), ($Million), 2023-2035

  • 3.1 Hospitals and Clinics
  • 3.2 Ambulatory Surgical Centers
  • 3.3 Others

4 Global Interventional Ultrasound Market (by Region), ($Million), 2023-2035

  • 4.1 North America
    • 4.1.1 Regional Overview
    • 4.1.2 Driving Factors for Market Growth
    • 4.1.3 Factors Challenging the Market
    • 4.1.4 Market Sizing and Forecast
      • 4.1.4.1 North America Interventional Ultrasound Market, by Application
      • 4.1.4.2 North America Interventional Ultrasound Market, by End User
      • 4.1.4.3 North America Interventional Ultrasound Market, by Country
        • 4.1.4.3.1 U.S.
          • 4.1.4.3.1.1 Country Overview
          • 4.1.4.3.1.2 Market Sizing and Forecast
          • 4.1.4.3.1.2.1 U.S. Interventional Ultrasound Market, by End User
        • 4.1.4.3.2 Canada
          • 4.1.4.3.2.1 Country Overview
          • 4.1.4.3.2.2 Market Sizing and Forecast
          • 4.1.4.3.2.2.1 Canada Interventional Ultrasound Market, by End User
  • 4.2 Europe
    • 4.2.1 Regional Overview
    • 4.2.2 Driving Factors for Market Growth
    • 4.2.3 Factors Challenging the Market
    • 4.2.4 Market Sizing and Forecast
      • 4.2.4.1 Europe Interventional Ultrasound Market, by Application
      • 4.2.4.2 Europe Interventional Ultrasound Market, by End User
      • 4.2.4.3 Europe Interventional Ultrasound Market, by Country
        • 4.2.4.3.1 U.K.
          • 4.2.4.3.1.1 Country Overview
          • 4.2.4.3.1.2 Market Sizing and Forecast
          • 4.2.4.3.1.2.1 U.K. Interventional Ultrasound Market, by End User
        • 4.2.4.3.2 France
          • 4.2.4.3.2.1 Country Overview
          • 4.2.4.3.2.2 Market Sizing and Forecast
          • 4.2.4.3.2.2.1 France Interventional Ultrasound Market, by End User
        • 4.2.4.3.3 Germany
          • 4.2.4.3.3.1 Country Overview
          • 4.2.4.3.3.2 Market Sizing and Forecast
          • 4.2.4.3.3.2.1 Germany Interventional Ultrasound Market, by End User
        • 4.2.4.3.4 Italy
          • 4.2.4.3.4.1 Country Overview
          • 4.2.4.3.4.2 Market Sizing and Forecast
          • 4.2.4.3.4.2.1 Italy Interventional Ultrasound Market, by End User
        • 4.2.4.3.5 Spain
          • 4.2.4.3.5.1 Country Overview
          • 4.2.4.3.5.2 Market Sizing and Forecast
          • 4.2.4.3.5.2.1 Spain Interventional Ultrasound Market, by End User
        • 4.2.4.3.6 Rest-of-Europe
          • 4.2.4.3.6.1 Country Overview
          • 4.2.4.3.6.2 Market Sizing and Forecast
          • 4.2.4.3.6.3 Rest-of-Europe Interventional Ultrasound Market, by End User
  • 4.3 Asia-Pacific
    • 4.3.1 Regional Overview
    • 4.3.2 Driving Factors for Market Growth
    • 4.3.3 Factors Challenging the Market
    • 4.3.4 Market Sizing and Forecast
      • 4.3.4.1 Asia-Pacific Interventional Ultrasound Market, by Application
      • 4.3.4.2 Asia-Pacific Interventional Ultrasound Market, by End User
      • 4.3.4.3 Asia-Pacific Interventional Ultrasound Market, by Country
        • 4.3.4.3.1 Japan
          • 4.3.4.3.1.1 Country Overview
          • 4.3.4.3.1.2 Market Sizing and Forecast
          • 4.3.4.3.1.2.1 Japan Interventional Ultrasound Market, by End User
        • 4.3.4.3.2 China
          • 4.3.4.3.2.1 Country Overview
          • 4.3.4.3.2.2 Market Sizing and Forecast
          • 4.3.4.3.2.3 China Interventional Ultrasound Market, by End User
        • 4.3.4.3.3 India
          • 4.3.4.3.3.1 Country Overview
          • 4.3.4.3.3.2 Market Sizing and Forecast
          • 4.3.4.3.3.2.1 India Interventional Ultrasound Market, by End User
        • 4.3.4.3.4 Australia
          • 4.3.4.3.4.1 Country Overview
          • 4.3.4.3.4.2 Market Sizing and Forecast
          • 4.3.4.3.4.2.1 Australia Interventional Ultrasound Market, by End User
        • 4.3.4.3.5 South Korea
          • 4.3.4.3.5.1 Country Overview
          • 4.3.4.3.5.2 Market Sizing and Forecast
          • 4.3.4.3.5.2.1 South Korea Interventional Ultrasound Market, by End User
        • 4.3.4.3.6 Rest-of-Asia-Pacific
          • 4.3.4.3.6.1 Country Overview
          • 4.3.4.3.6.2 Market Sizing and Forecast
          • 4.3.4.3.6.2.1 Rest-of-Asia-Pacific Interventional Ultrasound Market, by End User
  • 4.4 Latin America
    • 4.4.1 Regional Overview
    • 4.4.2 Driving Factors for Market Growth
    • 4.4.3 Factors Challenging the Market
    • 4.4.4 Market Sizing and Forecast
      • 4.4.4.1 Latin America Interventional Ultrasound Market, by Application
      • 4.4.4.2 Latin America Interventional Ultrasound Market, by End User
      • 4.4.4.3 Latin America Interventional Ultrasound Market, by Country
        • 4.4.4.3.1 Brazil
          • 4.4.4.3.1.1 Country Overview
          • 4.4.4.3.1.2 Market Sizing and Forecast
          • 4.4.4.3.1.2.1 Brazil Interventional Ultrasound Market, by End User
        • 4.4.4.3.2 Mexico
          • 4.4.4.3.2.1 Country Overview
          • 4.4.4.3.2.2 Market Sizing and Forecast
          • 4.4.4.3.2.3 Mexico Interventional Ultrasound Market, by End User
        • 4.4.4.3.3 Rest-of-Latin America
          • 4.4.4.3.3.1 Country Overview
          • 4.4.4.3.3.2 Market Sizing and Forecast
          • 4.4.4.3.3.2.1 Rest-of-Latin America Interventional Ultrasound Market, by End User
  • 4.5 Middle East and Africa
    • 4.5.1 Regional Overview
    • 4.5.2 Driving Factors for Market Growth
    • 4.5.3 Factors Challenging the Market
    • 4.5.4 Market Sizing and Forecast
      • 4.5.4.1 Middle East and Africa Interventional Ultrasound Market, by Application
      • 4.5.4.2 Middle East and Africa Interventional Ultrasound Market, by End User

5 Competitive Landscape and Company Profiles

  • 5.1 Competitive Landscape
  • 5.2 Company Profiles
    • 5.2.1 Canon Inc.
      • 5.2.1.1 Overview
      • 5.2.1.2 Top Products/Product Portfolio
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Target Customers
      • 5.2.1.5 Key Personal
      • 5.2.1.6 Analyst View
    • 5.2.2 DeepSight Technology, Inc.
      • 5.2.2.1 Overview
      • 5.2.2.2 Top Products/Product Portfolio
      • 5.2.2.3 Top Competitors
      • 5.2.2.4 Target Customers
      • 5.2.2.5 Key Personal
      • 5.2.2.6 Analyst View
    • 5.2.3 Edan Instruments
      • 5.2.3.1 Overview
      • 5.2.3.2 Top Products/Product Portfolio
      • 5.2.3.3 Top Competitors
      • 5.2.3.4 Target Customers
      • 5.2.3.5 Key Personal
      • 5.2.3.6 Analyst View
    • 5.2.4 Esaote SPA
      • 5.2.4.1 Overview
      • 5.2.4.2 Top Products/Product Portfolio
      • 5.2.4.3 Top Competitors
      • 5.2.4.4 Target Customers
      • 5.2.4.5 Key Personal
      • 5.2.4.6 Analyst View
    • 5.2.5 FUJIFILM Holdings Corporation
      • 5.2.5.1 Overview
      • 5.2.5.2 Top Products/Product Portfolio
      • 5.2.5.3 Top Competitors
      • 5.2.5.4 Target Customers
      • 5.2.5.5 Key Personal
      • 5.2.5.6 Analyst View
    • 5.2.6 GE HealthCare
      • 5.2.6.1 Overview
      • 5.2.6.2 Top Products/Product Portfolio
      • 5.2.6.3 Top Competitors
      • 5.2.6.4 Target Customers
      • 5.2.6.5 Key Personal
      • 5.2.6.6 Analyst View
    • 5.2.7 Konica Minolta, Inc.
      • 5.2.7.1 Overview
      • 5.2.7.2 Top Products/Product Portfolio
      • 5.2.7.3 Top Competitors
      • 5.2.7.4 Target Customers
      • 5.2.7.5 Key Personal
      • 5.2.7.6 Analyst View
    • 5.2.8 Koninklijke Philips N.V.
      • 5.2.8.1 Overview
      • 5.2.8.2 Top Products/Product Portfolio
      • 5.2.8.3 Top Competitors
      • 5.2.8.4 Target Customers
      • 5.2.8.5 Key Personal
      • 5.2.8.6 Analyst View
    • 5.2.9 Samsung Healthcare
      • 5.2.9.1 Overview
      • 5.2.9.2 Top Products/Product Portfolio
      • 5.2.9.3 Top Competitors
      • 5.2.9.4 Target Customers
      • 5.2.9.5 Key Personal
      • 5.2.9.6 Analyst View
    • 5.2.10 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 5.2.10.1 Overview
      • 5.2.10.2 Top Products/Product Portfolio
      • 5.2.10.3 Top Competitors
      • 5.2.10.4 Target Customers
      • 5.2.10.5 Key Personal
      • 5.2.10.6 Analyst View
    • 5.2.11 Siemens Healthineers AG
      • 5.2.11.1 Overview
      • 5.2.11.2 Top Products/Product Portfolio
      • 5.2.11.3 Top Competitors
      • 5.2.11.4 Target Customers
      • 5.2.11.5 Key Personal
      • 5.2.11.6 Analyst View
    • 5.2.12 SonoScape Medical Corp.
      • 5.2.12.1 Overview
      • 5.2.12.2 Top Products/Product Portfolio
      • 5.2.12.3 Top Competitors
      • 5.2.12.4 Target Customers
      • 5.2.12.5 Key Personal
      • 5.2.12.6 Analyst View

6 Research Methodology

  • 6.1 Data Sources
    • 6.1.1 Primary Data Sources
    • 6.1.2 Secondary Data Sources
    • 6.1.3 Data Triangulation
  • 6.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Interventional Ultrasound Market (by Scenario), $Million, 2025, 2029, and 2035
  • Figure 2: Global Interventional Ultrasound Market, 2025 and 2035
  • Figure 3: Top Countries, Global Interventional Ultrasound Market, $Million, 2024
  • Figure 4: Global Interventional Ultrasound Market, $Million, 2025 and 2035
  • Figure 5: Global Interventional Ultrasound Market (by Application), $Million, 2025, 2029, and 2035
  • Figure 6: Global Interventional Ultrasound Market (by End User), in Million, 2025, 2029, and 2035
  • Figure 7: Areas of ML Integration in Ultrasound Systems
  • Figure 8: Number of Patents Files (by Country), January 2021 to May 2025
  • Figure 9: Number of Patents Files (by Year), January 2021 to May 2025
  • Figure 10: Incidence of Cancer (by Region), 2020-2040
  • Figure 11: Volumetric Ultrasound Device
  • Figure 12: Global Interventional Ultrasound Market (by Application), $Million, 2025, 2029, and 2035
  • Figure 13: Global Interventional Ultrasound Market (General Surgery), $Million, 2023-2035
  • Figure 14: Global Interventional Ultrasound Market (Cancer), $Million, 2023-2035
  • Figure 15: Global Interventional Ultrasound Market (Lung Cancer), $Million, 2023-2035
  • Figure 16: Global Interventional Ultrasound Market (Breast Cancer), $Million, 2023-2035
  • Figure 17: Global Interventional Ultrasound Market (Liver Cancer), $Million, 2023-2035
  • Figure 18: Global Interventional Ultrasound Market (Kidney Cancer), $Million, 2023-2035
  • Figure 19: Global Interventional Ultrasound Market (Prostate Cancer), $Million, 2023-2035
  • Figure 20: Global Interventional Ultrasound Market (Other Cancer Types), $Million, 2023-2035
  • Figure 21: Global Interventional Ultrasound Market (Cardiac and Endovascular), $Million, 2023-2035
  • Figure 22: Global Interventional Ultrasound Market (Others), $Million, 2023-2035
  • Figure 23: Global Interventional Ultrasound Market (by End User), $Million, 2025, 2029, and 2035
  • Figure 24: Global Interventional Ultrasound Market (Hospital and Clinics), $Million, 2023-2035
  • Figure 25: Global Interventional Ultrasound Market (Ambulatory Surgical Centers), $Million, 2023-2035
  • Figure 26: Global Interventional Ultrasound Market (Others), $Million, 2023-2035
  • Figure 27: North America Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 28: U.S. Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 29: Canada Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 30: Europe Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 31: U.K. Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 32: France Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 33: Germany Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 34: Italy Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 35: Spain Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 36: Rest-of-Europe Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 37: Asia-Pacific Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 38: Japan Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 39: China Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 40: India Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 41: Australia Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 42: South Korea Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 43: Rest-of-Asia-Pacific Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 44: Latin America Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 45: Brazil Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 46: Mexico Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 47: Rest-of-Latin America Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 48: Middle East and Africa Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 49: Strategic Initiatives, January 2021-May 2025
  • Figure 50: Data Triangulation
  • Figure 51: Top-Down and Bottom-Up Approach
  • Figure 52: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Key Market Trends
  • Table 3: Some of the Ongoing Activity in AI in Ultrasound Systems
  • Table 4: Some of the Recent Product Launches in Interventional Ultrasound Market
  • Table 5: Price of Interventional Ultrasound Systems
  • Table 6: Market Dynamics
  • Table 7: Global Interventional Ultrasound Market (by Region), $Million, 2023-2035
  • Table 8: North America Interventional Ultrasound Market (by Application), $Million, 2023-2035
  • Table 9: North America Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 10: North America Interventional Ultrasound Market (by Country), $Million, 2023-2035
  • Table 11: U.S. Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 12: Canada Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 13: Europe Interventional Ultrasound Market (by Application), $Million, 2023-2035
  • Table 14: Europe Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 15: Europe Interventional Ultrasound Market (by Country), $Million, 2023-2035
  • Table 16: U.K. Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 17: France Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 18: Germany Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 19: Italy Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 20: Spain Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 21: Rest-of-Europe Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 22: Asia-Pacific Interventional Ultrasound Market (by Application), $Million, 2023-2035
  • Table 23: Asia-Pacific Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 24: Asia-Pacific Interventional Ultrasound Market (by Country), $Million, 2023-2035
  • Table 25: Japan Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 26: China Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 27: India Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 28: Australia Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 29: South Korea Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 30: Rest-of-Asia-Pacific Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 31: Latin America Interventional Ultrasound Market (by Application), $Million, 2023-2035
  • Table 32: Latin America Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 33: Latin America Interventional Ultrasound Market (by Country), $Million, 2023-2035
  • Table 34: Brazil Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 35: Mexico Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 36: Rest-of-Latin America Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 37: Middle East and Africa Interventional Ultrasound Market (by Application), $Million, 2023-2035
  • Table 38: Middle East and Africa Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 39: Global Market Share, 2024